4//SEC Filing
DAVIS A BRIAN 4
Accession 0001179110-19-002285
CIK 0001634432other
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 8:50 AM ET
Size
6.9 KB
Accession
0001179110-19-002285
Insider Transaction Report
Form 4
DAVIS A BRIAN
Chief Financial Officer
Transactions
- Award
Ordinary Shares
2019-02-20+20,000→ 33,366 total - Award
Employee Stock Option (right to buy)
2019-02-20+108,500→ 108,500 totalExercise: $4.67Exp: 2029-02-20→ Common Stock (108,500 underlying)
Footnotes (2)
- [F1]Represents a grant of restricted stock units, which vest in full on February 20, 2021, provided the Reporting Person is employed by the Issuer on such date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]This option vests in sixteen equal quarterly installments beginning May 20, 2019, provided the Reporting Person is employed by the Issuer on each vesting date.
Documents
Issuer
Strongbridge Biopharma plc
CIK 0001634432
Entity typeother
Related Parties
1- filerCIK 0001184432
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 8:50 AM ET
- Size
- 6.9 KB